Savant Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $673K | Sell |
1,281
-2,607
| -67% | -$1.37M | ﹤0.01% | 959 |
|
|
2025
Q1 | $2.47M | Buy |
3,888
+2,903
| +295% | +$1.84M | 0.02% | 460 |
|
|
2024
Q4 | $701K | Buy |
985
+172
| +21% | +$122K | 0.01% | 777 |
|
|
2024
Q3 | $855K | Buy |
813
+189
| +30% | +$199K | 0.01% | 698 |
|
|
2024
Q2 | $656K | Buy |
624
+75
| +14% | +$78.8K | 0.01% | 707 |
|
|
2024
Q1 | $528K | Buy |
549
+35
| +7% | +$33.7K | 0.01% | 711 |
|
|
2023
Q4 | $451K | Buy |
514
+117
| +29% | +$103K | 0.01% | 589 |
|
|
2023
Q3 | $327K | Buy |
397
+26
| +7% | +$21.4K | ﹤0.01% | 631 |
|
|
2023
Q2 | $267K | Buy |
371
+5
| +1% | +$3.59K | ﹤0.01% | 676 |
|
|
2023
Q1 | $301K | Buy |
+366
| New | +$301K | 0.01% | 593 |
|
|
2022
Q4 | – | Sell |
-322
| Closed | -$222K | – | 609 |
|
|
2022
Q3 | $222K | Buy |
+322
| New | +$222K | 0.01% | 490 |
|
|
2022
Q2 | – | Sell |
-324
| Closed | -$226K | – | 579 |
|
|
2022
Q1 | $226K | Buy |
+324
| New | +$226K | 0.01% | 518 |
|
|
2020
Q3 | – | Sell |
-360
| Closed | -$225K | – | 411 |
|
|
2020
Q2 | $225K | Buy |
+360
| New | +$225K | 0.02% | 362 |
|
|
2017
Q3 | – | Sell |
-480
| Closed | -$236K | – | 276 |
|
|
2017
Q2 | $236K | Buy |
+480
| New | +$236K | 0.06% | 239 |
|